Short-term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders

Neurology

Volumn 45, Issue 6, 1995, Pages 1193-1198

  De Stefano, N ^a   Matthews, P M ^a,b   Ford, B ^c   Genge, A ^a   Karpati, G ^a   Arnold, D L ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DICHLOROACETIC ACID;

ADOLESCENT; ADULT; AEROBIC METABOLISM; AGED; ARTICLE; BRAIN METABOLISM; CELL DENSITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENCEPHALOMYOPATHY; FEMALE; HUMAN; LACTATE BLOOD LEVEL; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0029072626     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.45.6.1193     Document Type: Article

References (38)

1. DiMauro S, Bonilla E, Zeviani M, Nakagawa M, DeVivo DC. Mitochondrial myopathies [review]. Ann Neurol 1985; 17:521-538.
2. Karpati G, Arnold D, Matthews P, Carpenter S, Andermann F, Shoubridge E. Correlative multidisciplinary approach to the study of mitochondrial encephalomyopathies. Rev Neurol (Paris) 1991;147:455-461.
3. Przyrembel H. Therapy of mitochondrial disorders. J Inherit Metab Dis 1987;10:129-146.
4. Bresolin N, Doriguzzi C, Ponzetto C, et al. Ubidecarenone in the treatment of mitochondrial myopathies: a multi-center double-blind trial. J Neurol Sci 1990;100:70-78.
5. 10 for mitochondrial myopathies. Prog Neuropathol 1991;7:215-223.
6. Tulinius MH, Eriksson BO, Hjalmarson O, Holme E, Oldfors A. Mitochondrial myopathy and cardiomyopathy in siblings. Pediatr Neurol 1989;5:182-188.
7. 31P-NMR follow-up study. Ann Neurol 1986; 19:598-602.
8. de Visser M, Scholte HR, Schutgens RBH, et al. Riboflavin-responsive lipid-storage myopathy and glutaric aciduria type II of early adult onset. Neurology 1986;36:367-372.
9. Arts WF, Scholte HR, Bogaard JM, Kerrebijn KF, Luyt-Houwen IE. NADH-CoQ reductase deficient myopathy: successful treatment with riboflavin [letter]. Lancet 1983; 2:581-582.
10. 10 arid idebenone. J Neurol Sci 1989;90:263-271.
11. 31P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathies. Neurology 1992;42:1203-1208.
12. Ogasahara S, Engel AG, Frens D, Mack D. Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. Proc Natl Acad Sci USA 1989;86:2379-2382.
13. 10 in a patient with mitochondrial encephalomyopathy. J Neurol 1987;234:62-63.
14. Yamamoto M, Sato T, Anno M, Ujike H, Takemoto M. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes with recurrent abdominal symptoms and coenzyme Q10 administration. J Neurol Neurosurg Psychiatry 1987;50:1475-1481.
15. 3 and C in a patient with a defect in electron transport at complex III in skeletal muscle. Proc Natl Acad Sci USA 1984;81:3529-3533.
16. 10 with multiple vitamins is generally ineffective in treatment of mitochondrial disease. Neurology 1993;43:884-890.
17. Stacpoole PW, Greene YJ. Dichloroacetate [review]. Diabetes Care 1992;15:785-791.
18. Whitehouse S, Cooper RH, Randle PJ. Mechanism of activation of pyruvate dehydrogenase by dichloroacetate and other halogenated carboxylic acids. Biochem J 1974;141:761-774.
19. Stacpoole PW, Lorenz AC, Thomas RG, Harman EM. Dichloroacetate in the treatment of lactic acidosis. Ann Intern Med 1988;108:58-63.
20. Kuroda Y, Ito M, Toshima K, et al. Treatment of chronic congenital lactic acidosis by oral administration of dichloroacetate. J Inherit Metab Dis 1986;9:244-252.
21. Stacpoole PW, Harman EM, Curry SH, Baumgartner TG, Misbin RI. Treatment of lactic acidosis with dichloroacetate. N Engl J Med 1983;309:390-396.
22. Stacpoole PW. The pharmacology of dichloroacetate [review]. Metabolism 1989;38:1124-1144.
23. Okabe I, Kodama H, Shimoizumi H, Kamoshita S, Miyabayashi S. Treatment of lactic acidosis: effect of dichloroacetate on lactate and pyruvate levels in the cerebrospinal fluid [letter]. Eur J Pediatr 1986;9:244-252.
24. Ludvik B, Peer G, Berzlanoivich A, Stifter S, Grag H. Effects of dichloroacetate and bicarbonate on haemodynamic parameters in healthy volunteers. Clin Sci (Colch) 1991; 80:47-51.
25. Burlina AB, Milanesi O, Biban P, et al. Beneficial effect of sodium dichloroacetate in muscle cytochrome c oxidase deficiency [letter]. Eur J Pediatr 1993;152:537.
26. Saijo T, Naito E, Ito M, Takeda E, Hashimoto T, Kuroda Y. Therapeutic effect of sodium dichloroacetate on visual and auditory hallucinations in a patient with MELAS. Neuropediatrics 1991;22:166-167.
27. Naito E, Kuroda Y, Toshima K, et al. Effect of sodium dichloroacetate on human pyruvate metabolism. Brain Dev 1989;11:195-197.
28. Curry SH, Lorenz A, Chu PI, Limacher M, Stacpoole PW. Disposition and pharmacodynamics of dichloroacetate (DCA) and oxalate following oral DCA doses. Biopharm Drug Dispos 1991;12:375-390.
29. Matthews PM, Allaire C, Shoubridge EA, Karpati G, Carpenter S, Arnold DL. In vivo muscle magnetic resonance spectroscopy in the clinical investigation of mitochondrial disease. Neurology 1991;41:114-120.
30. 31P NMR. Magn Reson Med 1984;1:307-315.
31. Arnold DL, Taylor DJ, Radda GK. Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy. Ann Neurol 1985;18:189-196.
32. Ordidge RJ, Mansfield P, Lohman JA. Volume selection using gradients and selective pulses. Ann NY Acad Sci 1987;508:376-385.
33. Simmons ML, Frondoza CG, Coyle JT. Immunocytochemical localization of N-acetylaspartate with monoclonal antibodies. Neuroscience 1991;45:37-45.
34. Moffett JR, Namboodiri MAA, Cangro CB, Neale JH. Immunohistochemical localization of N-acetylaspartate in rat brain. Neuroreport 1991;2:131-134.
35. Matthews PM, Francis G, Antel J, Arnold DL. Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis. Neurology 1991;41:1251-1256.
36. 31P magnetic resonance spectroscopy of the brain in degenerative cerebral disorders. Ann Neurol 1992;31:202-211.
37. Matthews PM, Andermann F, Silver K, Karpati G, Arnold DL. Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies. Neurology 1993;43:2484-2490.
38. Stacpoole PW, Wright EC, Baumgartner TG, et al. A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults. The Dichloroacetate-Lactic Acidosis Study Group. N Engl J Med 1992;327:1564-1569.